Home / Publications / Prices for essential drug list medicines subject to...

Prices for essential drug list medicines subject to mandatory re-registration in Russia

Japanese version

24/06/2019

On 7 June 2019, a law establishing new requirements for the re-registration of prices for essential drug list medicines came into force in Russia.

The law provides for the mandatory re-registration of prices for all EDL medicines in 2019 and 2020. It also establishes stricter requirements for marketing authorisation holders in relation to monitoring EDL medicine prices and applying for changes to the Register of Registered Prices.

Please find below the Japanese version of the update.

English version is available here.

Publication
CMS Russia_Prices for essential drug list medicines subject to mandatory re-registration in Russia (Japanese)
Download
PDF 206 kB

Authors

Daneliya Georgy
Georgy Daneliya
Counsel
Moscow
Vsevolod Tyupa
Vsevolod Tyupa
Counsel
Moscow
Alexey Shadrin